199 related articles for article (PubMed ID: 13831238)
1. [Study of the anabolic action of 19-nortestosterone phenylpropionate. Preliminary note].
de SALCEDO ; BORGES F; GODINHO P
J Med (Oporto); 1960 Nov; 43():599-600. PubMed ID: 13831238
[No Abstract] [Full Text] [Related]
2. [Studies on anabolic agents. I. Comparative study of the anabolic action of methandrostenolone (MA) and of 19-nortestosterone phenylpropionate (NTP) in the same individuals. II. Anabolic action of a depot form of methandrostenolone].
de SALCEDO ; SOUSA CG
J Med (Oporto); 1962 Apr; 47():979-82. PubMed ID: 14496307
[No Abstract] [Full Text] [Related]
3. [Anabolic and metabolic effects during nor-androstenolone phenylpropionate (NAPP) therapy].
DEMOLE R; THIERY M; FRANCOIS-TERMONT E; BEKAERT J; PEETERS H; VUYLSTEKE P
Praxis; 1960 May; 49():477-86. PubMed ID: 13815860
[No Abstract] [Full Text] [Related]
4. [Therapeutic study of a new anabolic drug: nor-androstenolone phenylpropionate].
ZARA M; LUMBROSO A
Sem Hop Ther Paris; 1960 May; 36():454-7. PubMed ID: 13847031
[No Abstract] [Full Text] [Related]
5. Catabolic effect of dihydrotachysterol and anabolic action of 17-ethyl-19-nortestosterone on the uptake of radio sulphur in a healing fractured bone of the rat.
KOWALEWSKI K
Acta Endocrinol (Copenh); 1958 May; 28(1):119-23. PubMed ID: 13532383
[No Abstract] [Full Text] [Related]
6. [Preliminary clinical trials with the phenylpropionate of norandrostenolone (PPNA) as a protein anabolizing agent].
HUGUENARD P; GODARD H
Therapie; 1959; 14():738-44. PubMed ID: 14403896
[No Abstract] [Full Text] [Related]
7. [Anabolic activity of 19-nortestosterone propionate].
AMMANITI L; PALMA F
Policlinico Prat; 1958 Feb; 65(8):301-5. PubMed ID: 13553831
[No Abstract] [Full Text] [Related]
8. Preliminary report of a long acting anabolic agent, nandrolone decanoate.
CRAIG PE
Clin Med (Northfield); 1962 May; 69():1154-6. PubMed ID: 13881968
[No Abstract] [Full Text] [Related]
9. [Action of norandrostenolone phenylpropionate (N.A.P.P.) in experimental tumorization].
VERNE J; ROTH PC
Bull Assoc Fr Etud Cancer; 1961; 48():535-7. PubMed ID: 13925515
[No Abstract] [Full Text] [Related]
10. Effects of the synthetic anabolic steroid, 17-ethyl-19-nortestosterone, on serum proteins, lipoproteins and lipids in human subjects.
DANIELSON E; SACHS BA; WESTON RE
J Clin Endocrinol Metab; 1956 Oct; 16(10):1388-91. PubMed ID: 13367178
[No Abstract] [Full Text] [Related]
11. [Clinical use of norandrostenolone phenylpropionate].
VAN OS H; DEMEULEMEESTER J
Bull Soc Sci Med Grand Duche Luxemb; 1959 Oct; 96():287-307. PubMed ID: 13841117
[No Abstract] [Full Text] [Related]
12. Effects of some anabolic steroids on the growth in male and female rats.
FUJII T; MORITA Y; KOYAMA R
Endocrinol Jpn; 1962 Jun; 9():93-102. PubMed ID: 13895706
[No Abstract] [Full Text] [Related]
13. Effect of norandrostenolone phenylpropionate on the riboflavin content of blood.
MARKKANEN T
Ann Med Intern Fenn; 1962; 51():125-7. PubMed ID: 14469994
[No Abstract] [Full Text] [Related]
14. [Use of durabolin (19-nor-androstenolone phenylpropionate) in the therapy of progressive muscular dystrophy].
BEKENY G; KRAFT F; LANG S
Orv Hetil; 1960 Feb; 101():229-34. PubMed ID: 13798373
[No Abstract] [Full Text] [Related]
15. [The use of durabolin (19-nor-androstenolone phenylpropionate) in the therapy of progressive muscular dystrophy].
BEKENY G; KRAFT F; LANG S
Nervenarzt; 1960 Mar; 31():118-23. PubMed ID: 13798372
[No Abstract] [Full Text] [Related]
16. [The anabolizing action of 19-nortestosterone propionate].
AMMANITI L; PALMA F
Rass Clin Ter; 1958; 57(1):1-7. PubMed ID: 13554871
[No Abstract] [Full Text] [Related]
17. [The use of 19-nortestosterone propionate in pulmonary tuberculosis].
MIGLIOLI S; D'ERCOLE R
Policlinico Prat; 1960 Mar; 67():385-7. PubMed ID: 13853952
[No Abstract] [Full Text] [Related]
18. [Effect of norandrosterolone phenylpropionate (durabolin) in growth retardation in children].
BARTA ; CSERE M; NABRADY J
Gyermekgyogyaszat; 1960 Sep; 11():262-8. PubMed ID: 14448494
[No Abstract] [Full Text] [Related]
19. The clinical effect of norandrostenolone phenylpropionate (durabolin) in metastasizing mammary cancer patients.
MALMIO K; HISI-BRUMMER L; HORTLING H
Ann Med Intern Fenn; 1960; 49():121-29. PubMed ID: 14420398
[No Abstract] [Full Text] [Related]
20. [Importance of norandrostenolone phenylpropionate in psychiatric therapy].
BOITTELLE G; BOITTELLE-LENTULO C; DUMEZIL C
Ann Med Psychol (Paris); 1962 Feb; 120(1)():389-92. PubMed ID: 13870704
[No Abstract] [Full Text] [Related]
[Next] [New Search]
